10篇
您的检索式：作者名="ROSENSTOCKJ"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLTZ) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia显示文摘 | ROSENSTOCKJ SEMAN LJ JELASKA A | 2013 | Diabetes Obes Metab2013，，12： | 1 |
| 2 | Pregabalin forthe treatment of painful diabetic peripheral neuropa a double -blind,placebo-controlled trial显示文摘 | RosenstockJ Tuchman M Moreaux L | 2004 | Pain2004，110，3： | 1 |
| 3 | Reduced hy2poglycemia risk with insulin glargine:a meta analysis comparing insulin glargine with human NPH insulin in type 2 diabetes显示文摘 | RosenstockJ Dailey G Massi2BenedettiM | 2008 | D iabetes Care2008，28，4： | 1 |
| 4 | Canagliflozin compared withsitagliptin for patients with type 2 diabetes who do not have adequate glycemiccontrol with metformin plus sulfonylurea:a 52-week randomized trial显示文摘 | Schernthaner G Gross J L RosenstockJ | 2013 | Diabetes Care2013，36，9： | 1 |
| 5 | Potential of albiglutide, a long-acting GLP-l receptor agonist, in type 2 diabetes a randomized controlled trial exploring weekly, biweekly, and monthly dosing显示文摘 | ROSENSTOCKJ YANG F REUSCHJ | 2009 | Diabetes Care2009，32，10： | 1 |
| 6 | Effect of metformin and rosiglltazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial显示文摘 | FonsecaV RosenstockJ Patwardhan R Salzman A | 2000 | JAMA2000，283，13： | 1 |
| 7 | Cana- gliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with mefformin plus sulfooylurea: a 52-week randomized trial 显示文摘 | SCHEMTHANER G GROSSJL ROSENSTOCKJ etal | 2013 | Diabetes Care2013，36，9： | 1 |
| 8 | The treat-to-target trail : randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients显示文摘 | Riddle MC RosenstockJ Gerich J | 2003 | Diabetes Care2003，26，： | 1 |
| 9 | Basal insulin therapy 2diabetes :27 - week comparison of insulin glargine(HOM90I) and NPH insulin显示文摘 | RosenstockJ Schwartz SL ClarkC | 2001 | Diabetes Care2001，24，11： | 1 |
| 10 | Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomized, parallel-group, multinational, open-label trial (LEAD-6)显示文摘 | BuseJB RosenstockJ Sesti G | 2009 | Lancet2009，374，9683： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员